PRODUCT PHYSICAL CONSISTENCY ISSUE

This adverse event was reported 3307 times

These drugs are most commonly taken by patients reporting PRODUCT PHYSICAL CONSISTENCY ISSUE:

# Drug Count
0 LEUPROLIDE ACETATE 470
1 BUPRENORPHINE 191
2 CLASCOTERONE 190
3 NAPROXEN SODIUM 117
4 NAPROXEN SODIUM TABLET 107
5 POLYETHYLENE GLYCOL 3350 79
6 TESTOSTERONE 74
7 OMEPRAZOLE MAGNESIUM 62
8 ERGOCALCIFEROL 61
9 LEVOTHYROXINE SODIUM 60
See all common drugs associated with PRODUCT PHYSICAL CONSISTENCY ISSUE

PRODUCT PHYSICAL CONSISTENCY ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholecystokinin Analog [EPC] 7 0.0496
1 Polyene Antimicrobial [EPC] 6 0.0319
2 l-Triiodothyronine [EPC] 1 0.0256
3 Sucrose-specific Enzyme [EPC] 1 0.0152
4 Bile Acid Sequestrant [EPC] 58 0.0069
5 Surfactant [EPC] 6 0.0061
6 Melanin Synthesis Inhibitor [EPC] 4 0.0046
7 Pyrethroid [EPC] 6 0.0045
8 Androgen Receptor Inhibitor [EPC] 206 0.0034
9 Interleukin-17 Receptor A Antagonist [EPC] 3 0.0030
See all drug classes enriched for association with PRODUCT PHYSICAL CONSISTENCY ISSUE